The self-association of HMGB1 and its possible role in the binding to DNA and cell membrane receptors

FEBS Letters

Volumn 591, Issue 2, 2017, Pages 282-294

  Anggayasti, Wresti L ^a   Mancera, Ricardo L ^a   Bottomley, Steve ^a   Helmerhorst, Erik ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

DNA; HMGB1; oligomerisation; physicochemical factors; physiological condition; RAGE; self association; TLR

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; DNA; HIGH MOBILITY GROUP B1 PROTEIN; MEMBRANE RECEPTOR; METAL ION; TOLL LIKE RECEPTOR; ZINC ION; CELL SURFACE RECEPTOR; PROTEIN BINDING;

APOPTOSIS; CELL DAMAGE; CELL PH; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; IONIC STRENGTH; NONHUMAN; OLIGOMERIZATION; OXIDATION REDUCTION POTENTIAL; PHYSICAL CHEMISTRY; PROTEIN ACETYLATION; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RECEPTOR BINDING; REVIEW; ANIMAL; CELL MEMBRANE; METABOLISM; OSMOLARITY; OXIDATION REDUCTION REACTION;

ANIMALS; CELL MEMBRANE; DNA; HMGB1 PROTEIN; HUMANS; OSMOLAR CONCENTRATION; OXIDATION-REDUCTION; PROTEIN BINDING; RECEPTORS, CELL SURFACE;

EID: 85010851173     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1002/1873-3468.12545     Document Type: Review

References (86)

1. Sims GP, Rowe DC, Rietdijk ST, Herbst R and Coyle AJ (2010) HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28, 367–388.
2. Stros M (2010) HMGB proteins: interactions with DNA and chromatin. Biochim Biophys Acta 1799 (1-2), 101–133.
3. Sessa L and Bianchi ME (2007) The evolution of high mobility group box (HMGB) chromatin proteins in multicellular animals. Gene 387, 133–140.
4. Read CM, Cary PD, Crane-Robinson C, Driscoll PC and Norman DG (1993) Solution structure of a DNA-binding domain from HMG1. Nucleic Acids Res 21, 3427–3436.
5. Weir HM, Kraulis PJ, Hill CS, Raine AR, Laue ED and Thomas JO (1993) Structure of the HMG box motif in the B-domain of HMG1. EMBO J 12, 1311–1319.
6. Bianchi ME, Falciola L, Ferrari S and Lilley DM (1992) The DNA binding site of HMG1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. EMBO J 11, 1055–1063.
7. Sahu D, Debnath P, Takayama Y and Iwahara J (2008) Redox properties of the A-domain of the HMGB1 protein. FEBS Lett 582, 3973–3978.
8. Yang H, Antoine DJ, Andersson U and Tracey KJ (2013) The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol 93, 865–873.
9. Thomas JO and Stott K (2012) H1 and HMGB1: modulators of chromatin structure. Biochem Soc Trans 40, 341–346.
10. Stott K, Watson M, Howe FS, Grossmann JG and Thomas JO (2010) Tail-mediated collapse of HMGB1 is dynamic and occurs via differential binding of the acidic tail to the A and B domains. J Mol Biol 403, 706–722.
11. Watson M, Stott K and Thomas JO (2007) Mapping intramolecular interactions between domains in HMGB1 using a tail-truncation approach. J Mol Biol 374, 1286–1297.
12. Blair RH, Horn AE, Pazhani Y, Grado L, Goodrich JA and Kugel JF (2016) The HMGB1 C-terminal tail regulates DNA bending. J Mol Biol 428, 4060–4072.
13. Lee KB and Thomas JO (2000) The effect of the acidic tail on the DNA-binding properties of the HMG1,2 class of proteins: insights from tail switching and tail removal. J Mol Biol 304, 135–149.
14. Postnikov YV and Bustin M (2016) Functional interplay between histone H1 and HMG proteins in chromatin. Biochim Biophys Acta 1859, 462–467.
15. Catez F, Yang H, Tracey KJ, Reeves R, Misteli T and Bustin M (2004) Network of dynamic interactions between histone H1 and high-mobility-group proteins in chromatin. Mol Cell Biol 24, 4321–4328.
16. Cato L, Stott K, Watson M and Thomas JO (2008) The interaction of HMGB1 and linker histones occurs through their acidic and basic tails. J Mol Biol 384, 1262–1272.
17. Watson M, Stott K, Fischl H, Cato L and Thomas JO (2013) Characterization of the interaction between HMGB1 and H3 – a possible means of positioning HMGB1 in chromatin. Nucleic Acids Res 42, 848–859.
18. Polanska E, Pospisilova S and Stros M (2013) Binding of histone H1 to DNA is differentially modulated by redox state of HMGB1. PLoS One 9, e89070.
19. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A and Abraham E (2004) Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279, 7370–7377.
20. Lu B, Wang C, Wang M, Li W, Chen F, Tracey KJ and Wang H (2014) Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review. Expert Rev Clin Immunol 10, 713–727.
21. Lu B, Antoine DJ, Kwan K, Lundbäck P, Wähämaa H, Schierbeck H, Robinson M, Van Zoelen MA, Yang H, Li J et al. (2014) JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proc Natl Acad Sci USA 111, 3068–3073.
22. Lee LC, Chen CM, Wang PR, Su MT, Lee-Chen GJ and Chang CY (2014) Role of high mobility group box 1 (HMGB1) in SCA17 pathogenesis. PLoS One 9, e115809.
23. Kim CH, Jeon HM, Lee SY, Jeong EK, Ju MK, Park BJ, Park HG, Lim SC, Han SI, Kang HS et al. (2010) Role of reactive oxygen species-dependent protein aggregation in metabolic stress-induced necrosis. Int J Oncol 37, 97–102.
24. Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, Huang J, Yu Y, Fan XG, Yan Z et al. (2014) HMGB1 in health and disease. Mol Aspects Med 40, 1–116.
25. Zhu S, Li W, Ward MF, Sama AE and Wang H (2010) High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation. Inflamm Allergy Drug Targets 9, 60–72.
26. Xie J, Reverdatto S, Frolov A, Hoffmann R, Burz DS and Shekhtman A (2008) Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J Biol Chem 283, 27255–27269.
27. Leventhal JS and Schroppel B (2012) Toll-like receptors in transplantation: sensing and reacting to injury. Kidney Int 81, 826–832.
28. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A et al. (2006) High mobility group box 1 protein interacts with multiple toll-like receptors. Am J Physiol Cell Physiol 290, C917–C924.
29. Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J, Lu B, Chavan S, Rosas-Ballina M, Al-Abed Y et al. (2010) A critical cysteine is required for HMGB1 binding to toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci USA 107, 11942–11947.
30. Ibrahim ZA, Armour CL, Phipps S and Sukkar MB (2013) RAGE and TLRs: relatives, friends or neighbours? Mol Immunol 56, 739–744.
31. Dasu MR, Devaraj S, Park S and Jialal I (2010) Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 33, 861–868.
32. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Elliston K, Stern D, Shaw A (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267, 14998–15004.
33. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, Clauss M et al. (1992) Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267, 14987–14997.
34. Yan SF, Yan SD, Ramasamy R and Schmidt AM (2009) Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation. Ann Med 41, 408–422.
35. Dattilo BM, Fritz G, Leclerc E, Kooi CW, Heizmann CW and Chazin WJ (2007) The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units. Biochemistry 46, 6957–6970.
36. Rouhiainen A, Kuja-Panula J, Wilkman E, Pakkanen J, Stenfors J, Tuominen RK, Lepäntalo M, Carpén O, Parkkinen J and Rauvala H (2004) Regulation of monocyte migration by amphoterin (HMGB1). Blood 104, 1174–1182.
37. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C et al. (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405, 354–360.
38. Kuniyasu H, Oue N, Wakikawa A, Shigeishi H, Matsutani N, Kuraoka K, Ito R, Yokozaki H and Yasui W (2002) Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J Pathol 196, 163–170.
39. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R and Rauvala H (2000) Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 275, 40096–40105.
40. Huttunen HJ, Fages C and Rauvala H (1999) Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 274, 19919–19924.
41. Huttunen HJ, Fages C, Kuja-Panula J, Ridley AJ and Rauvala H (2002) Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res 62, 4805–4811.
42. Sorci G, Riuzzi F, Giambanco I and Donato R (2013) RAGE in tissue homeostasis, repair and regeneration. Biochim Biophys Acta 1833, 101–109.
43. Musumeci D, Roviello GN and Montesarchio D (2014) An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol Ther 141, 347–357.
44. Dasu MR, Thangappan RK, Bourgette A, DiPietro LA, Isseroff R and Jialal I (2010) TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice. Lab Invest 90, 1628–1636.
45. Tsan MF and Gao B (2004) Endogenous ligands of toll-like receptors. J Leukoc Biol 76, 514–519.
46. Koch M, Chitayat S, Dattilo BM, Schiefner A, Diez J, Chazin WJ and Fritz G (2010) Structural basis for ligand recognition and activation of RAGE. Structure 18, 1342–1352.
47. Ostendorp T, Leclerc E, Galichet A, Koch M, Demling N, Weigle B, Heizmann CW, Kroneck PM and Fritz G (2007) Structural and functional insights into RAGE activation by multimeric S100B. EMBO J 26, 3868–3878.
48. Xie J, Burz DS, He W, Bronstein IB, Lednev I and Shekhtman A (2007) Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J Biol Chem 282, 4218–4231.
49. Moroz OV, Burkitt W, Wittkowski H, He W, Ianoul A, Novitskaya V, Xie J, Polyakova O, Lednev IK, Shekhtman A et al. (2009) Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function. BMC Biochem 10, 11.
50. Moroz OV, Dodson GG, Wilson KS, Lukanidin E and Bronstein IB (2003) Multiple structural states of S100A12: a key to its functional diversity. Microsc Res Tech 60, 581–592.
51. Duguet M and de Recondo AM (1978) A deoxyribonucleic acid unwinding protein isolated from regenerating rat liver. Physical and functional properties. J Biol Chem 253, 1660–1666.
52. Bonne C, Duguet M and de Recondo AM (1980) Single-strand DNA binding protein from rat liver: interactions with supercoiled DNA. Nucleic Acids Res 8, 4955–4968.
53. Grasser KD, Teo SH, Lee KB, Broadhurst RW, Rees C, Hardman CH and Thomas JO (1998) DNA-binding properties of the tandem HMG boxes of high-mobility-group protein 1 (HMG1). Eur J Biochem 253, 787–795.
54. Rauvala H, Pihlaskari R, Laitinen J and Merenmies J (1989) Extracellular adhesive molecules in neurite growth. Biosci Rep 9, 1–12.
55. Sanchez-Giraldo R, Acosta-Reyes FJ, Malarkey CS, Saperas N, Churchill ME and Campos JL (2015) Two high-mobility group box domains act together to underwind and kink DNA. Acta Crystallogr D Biol Crystallogr 71, 1423–1432.
56. Gangelhoff TA, Mungalachetty PS, Nix JC and Churchill ME (2009) Structural analysis and DNA binding of the HMG domains of the human mitochondrial transcription factor A. Nucleic Acids Res 37, 3153–3164.
57. Ritt C, Grimm R, Fernandez S, Alonso JC and Grasser KD (1998) Basic and acidic regions flanking the HMG domain of maize HMGa modulate the interactions with DNA and the self-association of the protein. Biochemistry 37, 2673–2681.
58. Mignotte B and Barat M (1986) Characterization of a Xenopus laevis mitochondrial protein with a high affinity for supercoiled DNA. Nucleic Acids Res 14, 5969–5980.
59. Antoshechkin I, Bogenhagen DF and Mastrangelo IA (1997) The HMG-box mitochondrial transcription factor xl-mtTFA binds DNA as a tetramer to activate bidirectional transcription. EMBO J 16, 3198–3206.
60. Fages C, Nolo R, Huttunen HJ, Eskelinen E and Rauvala H (2000) Regulation of cell migration by amphoterin. J Cell Sci 113 (Pt 4), 611–620.
61. Meng XY, Li B, Liu S, Kang H, Zhao L and Zhou R (2016) EGCG in green tea induces aggregation of HMGB1 protein through large conformational changes with polarized charge redistribution. Sci Rep 6, 22128.
62. Alexandrova EA and Beltchev BG (1987) Differences between HMG1 proteins isolated from normal and tumour cells. Biochim Biophys Acta 915, 399–405.
63. Stros M, Stokrova J and Thomas JO (1994) DNA looping by the HMG-box domains of HMG1 and modulation of DNA binding by the acidic C-terminal domain. Nucleic Acids Res 22, 1044–1051.
64. Anggayasti WL, Mancera RL, Bottomley S and Helmerhorst E (2016) The effect of physicochemical factors on the self-association of HMGB1: a surface plasmon resonance study. Biochim Biophys Acta 1864, 1620–1629.
65. Anggayasti WL, Mancera RL, Bottomley S and Helmerhorst E (2016) Optimization of surface plasmon resonance experiments: case of high mobility group box 1 (HMGB1) interactions. Anal Biochem 499, 43–50.
66. Mathis DJ, Kindelis A and Spadafora C (1980) HMG proteins (1+2) form beaded structures when complexed with closed circular DNA. Nucleic Acids Res 8, 2577–2590.
67. Tvedt KE, Kopstad G, Haugen OA and Halgunset J (1987) Subcellular concentrations of calcium, zinc, and magnesium in benign nodular hyperplasia of the human prostate: X-ray microanalysis of freeze-dried cryosections. Cancer Res 47, 323–328.
68. MacDonald RS (2000) The role of zinc in growth and cell proliferation. J Nutr 130, 1500S–1508S.
69. Ho E, Courtemanche C and Ames BN (2003) Zinc deficiency induces oxidative DNA damage and increases p53 expression in human lung fibroblasts. J Nutr 133, 2543–2548.
70. Vallee BL, Coleman JE and Auld DS (1991) Zinc fingers, zinc clusters, and zinc twists in DNA-binding protein domains. Proc Natl Acad Sci USA 88, 999–1003.
71. Gamsjaeger R, Liew CK, Loughlin FE, Crossley M and Mackay JP (2007) Sticky fingers: zinc-fingers as protein-recognition motifs. Trends Biochem Sci 32, 63–70.
72. Janko C, Filipovic M, Munoz LE, Schorn C, Schett G, Ivanovic-Burmazovic I and Herrmann M (2014) Redox modulation of HMGB1-related signaling. Antioxid Redox Signal 20, 1075–1085.
73. Park S and Lippard SJ (2011) Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA. Biochemistry 50, 2567–2574.
74. Wang J, Tochio N, Takeuchi A, Uewaki JI, Kobayashi N and Tate SI (2013) Redox-sensitive structural change in the A-domain of HMGB1 and its implication for the binding to cisplatin modified DNA. Biochem Biophys Res Commun 441, 701–706.
75. Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P, Hoppe G, Bianchi ME, Tracey KJ, Zeh HJ 3rd (2010) Endogenous HMGB1 regulates autophagy. J Cell Biol 190, 881–892.
76. Yang H, Lundbäck P, Ottosson L, Erlandsson-Harris H, Venereau E, Bianchi ME, Al-Abed Y, Andersson U, Tracey KJ and Antoine DJ (2012) Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med 18, 250–259.
77. Tang D, Billiar TR and Lotze MT (2012) A Janus tale of two active high mobility group box 1 (HMGB1) redox states. Mol Med 18, 1360–1362.
78. Ranatunga W, Lebowitz J, Axe B, Pavlik P, Kar SR and Scovell WM (1999) Reexamination of the high mobility group-1 protein for self-association and characterization of hydrodynamic properties. Biochim Biophys Acta 1432, 1–12.
79. Marekov LN, Demirov DG and Beltchev BG (1984) Isolation of high-mobility-group proteins HMG1 and HMG2 in non denaturing conditions and comparison of their properties with those of acid-extracted proteins. Biochim Biophys Acta 789, 63–68.
80. Wagner JP, Quill DM and Pettijohn DE (1995) Increased DNA-bending activity and higher affinity DNA binding of high mobility group protein HMG-1 prepared without acids. J Biol Chem 270, 7394–7398.
81. Rabbani A, Goodwin GH and Johns EW (1978) Studies on the tissue specificity of the high-mobility-group non-histone chromosomal proteins from calf. Biochem J 173, 497–505.
82. Goodwin GH, Nicolas RH and Johns EW (1975) An improved large scale fractionation of high mobility group non-histone chromatin proteins. Biochim Biophys Acta 405, 280–291.
83. Belgrano FS, de Abreu da Silva IC, Bastos de Oliveira FM, Fantappie MR and Mohana-Borges R (2013) Role of the acidic tail of high mobility group protein B1 (HMGB1) in protein stability and DNA bending. PLoS One 8, e79572.
84. Minton AP (2001) The influence of macromolecular crowding and macromolecular confinement on biochemical reactions in physiological media. J Biol Chem 276, 10577–10580.
85. Snoussi K and Halle B (2005) Protein self-association induced by macromolecular crowding: a quantitative analysis by magnetic relaxation dispersion. Biophys J 88, 2855–2866.
86. Phillip Y and Schreiber G (2013) Formation of protein complexes in crowded environments – from in vitro to in vivo. FEBS Lett 587, 1046–1052.